Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Lode Gold switches to semi-annual financial reporting to cut costs and focus on exploration.

Company Fundamentals
26 May 2026
Newsfile Corp
View Source
Neutral
pluang ai news

Lode Gold Resources Inc has adopted semi-annual financial reporting under a pilot program allowing venture issuers to reduce quarterly reporting burdens. This change will help the company save administrative costs and focus more on advancing its exploration and development projects. Lode Gold will no longer file quarterly interim financial statements but will continue to provide annual audited reports and six-month interim reports. The company remains committed to transparent disclosure and ongoing updates on its projects in Canada and the U.S., including the Fremont Gold Mine and Dingman Property.

More News

SpaceX IPO could trigger up to $27B in forced ETF buying due to Nasdaq rule changes, sparking potential lawsuits.

SpaceX IPO could trigger up to $27B in forced ETF buying due to Nasdaq rule changes, sparking potential lawsuits.

SpaceX's upcoming IPO may cause forced ETF buying of $22-$27 billion as Nasdaq changes rules to fast-track the company's index inclusion. The Nasdaq 100 now allows new companies to join within 15 days if their market cap ranks in the top 40, removing...

Market News
Bullish
1 hour ago
Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...

Market News
Bullish
2 hours ago
Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.

Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.

The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...

Market News
Bullish
3 hours ago
Poolbeg Pharma gets positive FDA feedback on cancer therapy POLB 001 development plan

Poolbeg Pharma gets positive FDA feedback on cancer therapy POLB 001 development plan

Poolbeg Pharma received positive feedback from the FDA during a pre-IND meeting for its lead cancer therapy candidate, POLB 001, aimed at preventing cytokine release syndrome (CRS), a side effect of cancer immunotherapy. The FDA broadly agreed with P...

Market News
Bullish
4 hours ago
Kingfisher sales dip in Q1 due to weather but remains on track for full-year profit guidance

Kingfisher sales dip in Q1 due to weather but remains on track for full-year profit guidance

Kingfisher PLC reported a 0.7% decline in underlying like-for-like sales for the first quarter ending April 30, impacted by poor weather and a late spring affecting footfall and seasonal demand. Despite this, total sales rose 1.4% to £3.3 billion, wi...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App